...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Identification of miR-133b and RB1CC1 as Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer
【24h】

Identification of miR-133b and RB1CC1 as Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer

机译:确定miR-133b和RB1CC1作为前列腺癌生化复发和潜在治疗目标的独立预测因子

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: We aimed to investigate the contribution of microRNA-133b (miR-133b) in prostate cancer cell proliferation, cell cycle, and apoptosis. We also examined expression of miR-133b in prostate cancer tissues, and evaluated the prognostic significance of miR-133b, as well as its target gene RB1CC1 in patients with prostate cancer after radical prostatectomy.
机译:目的:我们旨在研究microRNA-133b(miR-133b)在前列腺癌细胞增殖,细胞周期和凋亡中的作用。我们还检查了前列腺癌组织中miR-133b的表达,并评估了miR-133b及其靶基因RB1CC1在前列腺癌根治术后的患者的预后意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号